PEN - Financial Reports List - Penumbra, Inc. - IntrinsicAlpha

Penumbra, Inc. PEN

Healthcare - Medical - Devices - NYSE - US

$ 273.02

-2.42 %

$ 10.6 B

Market Cap

773.26

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	10.83%	-37.87%	22.11%
Annual Report	FY	10-K	2024-12-31	12.86%	-84.59%	-87.38%
Quarterly Report	Q3	8-K	2024-09-30	11.11%	220.46%	180.11%
Quarterly Report	Q2	8-K	2024-06-30	14.49%	-317.51%	-22.45%
Quarterly Report	Q1	8-K	2024-03-31	15.43%	28.50%	744.45%
Quarterly Report	Q4	8-K	2023-12-31	28.69%	1298.45%	2278.42%
Annual Report	FY	10-K	2023-12-31	24.95%	4643.16%	503.26%
Quarterly Report	Q3	8-K	2023-09-30	26.80%	505.72%	132.33%
Quarterly Report	Q2	8-K	2023-06-30	25.51%	614.24%	12969.78%
Quarterly Report	Q1	8-K	2023-03-31	18.39%	10737.97%	135.42%

1